ViewRay

company

About

ViewRay is a medical company that develops radiation therapy technology for the treatment of cancer.

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$30M
Industries
Biotechnology,Health Care,Manufacturing,Medical Device
Founded date
Jan 1, 2004
Number Of Employee
251 - 500
Operating Status
Active
Stock Symbol
nasdaq:VRAY
Legal Name
ViewRay Technologies, Inc.

ViewRay develops advanced radiation therapy technology for the treatment of cancer. It designs, manufactures, and markets MRIdian, an MRI-guided radiation therapy system that can image and treat cancer patients simultaneously. MRIdian addresses key limitations of existing external-beam radiation therapy technologies because it integrates MRI technology, radiation delivery, and proprietary software to locate, target, and track the position and shape of soft-tissue tumors while radiation is delivered. Real-time MRI-imaging clearly defines the targeted tumor from the surrounding soft tissue and other critical organs during radiation treatment allowing the system to deliver radiation to the tumor accurately while delivering less radiation to healthy tissue. MRIdian’s increased target accuracy combined with improved tumor visibility and accurate dose recording means clinicians can treat patients who would not previously have been considered radiation therapy candidates. ViewRay believes MRIdian will significantly improve the safety and efficacy of radiation therapy, leading to improved patient outcomes with reduced side effects from off-target radiation delivery.

The company was incorporated in 2004 and is based in Cleveland, Ohio.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
22
$877.79M
ViewRay has raised a total of $877.79M in funding over 2 rounds. Their latest funding was raised on Nov 14, 2022 from a Post-IPO Debt round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 14, 2022 Post-IPO Debt $125M 2 MidCap Financial
Silicon Valley Bank
Detail
Nov 19, 2021 Post-IPO Equity $80.50M Detail
Dec 6, 2019 Post-IPO Equity $36M 1 Elekta Detail
Jan 1, 2019 Debt Financing $56M 1 Detail
Aug 20, 2018 Post-IPO Equity $172.50M Detail

Investments

Number of Investments
Number of Lead Investments
2
0
ViewRay has made 2 investments. Their most recent investment was on Sep 1, 2013, when Pogoseat raised $800K.
Date Company Name
Round Money Raised Industry Lead Investor
Sep 1, 2013 Pogoseat
Seed $800K Concerts
Mar 23, 2011 Sosh
Seed $1M Apps

Employee Profiles

Number of Employee Profiles
10
ViewRay has 10 current employee profiles, including Board member Josh Bilenker
Board member
Executive
Executive
Employee
Executive